Wells Fargo’s MediWound MDWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$190K Sell
11,787
-8,396
-42% -$146K ﹤0.01% 4731
2025
Q4
$373K Buy
20,183
+5,306
+36% +$97K ﹤0.01% 4689
2025
Q3
$268K Buy
14,877
+766
+5% +$14.1K ﹤0.01% 4757
2025
Q2
$273K Sell
14,111
-102
-0.7% -$1.92K ﹤0.01% 4574
2025
Q1
$221K Sell
14,213
-75,208
-84% -$1.35M ﹤0.01% 4633
2024
Q4
$1.59M Sell
89,421
-5,344
-6% -$92.1K ﹤0.01% 3366
2024
Q3
$1.71M Sell
94,765
-37,269
-28% -$680K ﹤0.01% 3158
2024
Q2
$2.05M Buy
132,034
+769
+0.6% +$12.7K ﹤0.01% 2960
2024
Q1
$1.87M Sell
131,265
-839
-0.6% -$11.5K ﹤0.01% 3023
2023
Q4
$1.34M Sell
132,104
-4,538
-3% -$40.7K ﹤0.01% 3225
2023
Q3
$1.45M Buy
136,642
+23,915
+21% +$220K ﹤0.01% 3038
2023
Q2
$1.2M Buy
112,727
+15,535
+16% +$168K ﹤0.01% 3333
2023
Q1
$1.29M Sell
97,192
-5,300
-5% -$66.8K ﹤0.01% 3199
2022
Q4
$1.38M Sell
102,492
-11,120
-10% -$113K ﹤0.01% 3039
2022
Q3
$1.11M Buy
113,612
+17,387
+18% +$219K ﹤0.01% 3177
2022
Q2
$1.24M Buy
96,225
+28,448
+42% +$377K ﹤0.01% 3151
2022
Q1
$944K Buy
67,777
+21,680
+47% +$351K ﹤0.01% 3944
2021
Q4
$762K Buy
46,097
+5,034
+12% +$105K ﹤0.01% 4336
2021
Q3
$960K Buy
41,063
+2,987
+8% +$79.7K ﹤0.01% 4277
2021
Q2
$1.02M Buy
38,076
+259
+0.7% +$8K ﹤0.01% 4203
2021
Q1
$1.42M Sell
37,817
-75
-0.2% -$2.72K ﹤0.01% 3996
2020
Q4
$981K Buy
37,892
+2,627
+7% +$68.2K ﹤0.01% 4045
2020
Q3
$928K Sell
35,265
-1,931
-5% -$49.4K ﹤0.01% 3918
2020
Q2
$773K Buy
37,196
+5,855
+19% +$83.4K ﹤0.01% 4016
2020
Q1
$345K Buy
31,341
+4,273
+16% +$78.9K ﹤0.01% 4311
2019
Q4
$587K Sell
27,068
-4,073
-13% -$84.5K ﹤0.01% 4241
2019
Q3
$697K Buy
31,141
+3,673
+13% +$81.6K ﹤0.01% 4128
2019
Q2
$650K Sell
27,468
-312
-1% -$9.63K ﹤0.01% 4197
2019
Q1
$972K Buy
27,780
+5,033
+22% +$169K ﹤0.01% 3897
2018
Q4
$646K Buy
22,747
+83
+0.4% +$3.22K ﹤0.01% 4174
2018
Q3
$976K Sell
22,664
-470
-2% -$21.1K ﹤0.01% 3990
2018
Q2
$1.12M Buy
23,134
+5,802
+33% +$250K ﹤0.01% 3924
2018
Q1
$631K Buy
17,332
+2,876
+20% +$90.5K ﹤0.01% 4228
2017
Q4
$450K Buy
14,456
+6,624
+85% +$223K ﹤0.01% 4478
2017
Q3
$293K Sell
7,832
-1,563
-17% -$69K ﹤0.01% 4691
2017
Q2
$447K Buy
9,395
+1,789
+24% +$83.3K ﹤0.01% 4294
2017
Q1
$351K Buy
7,606
+1,249
+20% +$51.1K ﹤0.01% 4479
2016
Q4
$204K Buy
6,357
+2,607
+70% +$106K ﹤0.01% 4767
2016
Q3
$202K Buy
+3,750
New +$199K ﹤0.01% 4482
2015
Q1
Sell
-71
Closed -$3K 6274
2014
Q4
$3K Buy
+71
New +$2.91K ﹤0.01% 5956

Other funds holding MDWD

Wells Fargo's MDWD Position: Q1 2026 in Review

Wells Fargo reduced its MediWound (MDWD) stake by 42% in Q1 2026, selling an estimated $146K and leaving 11,787 shares worth $190K. The position accounts for ﹤0.01% of the portfolio, ranked #4731.

Wells Fargo first reported a position in MDWD in Q4 2014 and has held it in 40 quarters since. The position peaked at $2.05M in Q2 2024. 76 funds tracked by Wall St. Rank hold MDWD as of Q1 2026.

  • Wells Fargo held 11,787 shares of MediWound worth $190K as of Q1 2026.
  • Wells Fargo sold 8,396 MediWound shares in Q1 2026, an estimated $146K.
  • MediWound made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #4731 holding.
  • Wells Fargo first reported a position in MediWound in Q4 2014 and has held it in 40 quarters since.
  • Wells Fargo's MediWound position peaked at $2.05M in Q2 2024.
  • 76 funds tracked by Wall St. Rank held MediWound as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.